"/> Tocris™ YM 254890 | B-LABO France

Tocris™ YM 254890

Réf. : BL-RE-125716Réf. fabricant : 18739646 1 mg
526,98 € HT

Gα-protein inhibitor; potent inhibitor of Gq/11 signaling

Nom chimique ou matériau
(R)-1-((3 S,6 S,9 S,12 S,18 R,21 S,22 R)-21-acetamido-18-benzyl-3-((R)-1-methoxyethyl)-4,9,10,12,16,22-hexamethyl-15-methylene-2,5,8,11,14,17,20-heptaoxo-1,19-dioxa-4,7,10,13,16-pentaazacyclodocosan-6-yl)-2-methylpropyl (2 S,3 R)-2-acetamido-3-hydroxy-4-methylpent
CAS
568580-02-9
Quantité
1 mg
Cible
GTPase Inhibitors
Formule moléculaire
C46H69N7O15
Marque
Tocris

YM 254890 is a Gα-protein inhibitor. Potently inhibits Gq/11 heterotrimeric G protein signaling. Inhibits ATP/UTP-induced Ca2+ increase in HCAE cells expressing P2Y2 receptor (IC50 = 50 nM); carbachol-induced production of IP1 in CHO cells expressing M1 receptor (IC50 = 95 nM); and ADP-induced Ca2+ increase in platelets,

in vitro

(IC50 = 2 μM). Also inhibits Gs-induced cAMP elevation and G protein-coupled MAPK/ERK signaling.

Caractéristiques techniques

MarqueTocris
Réf. B-LABOBL-RE-125716
Réf. fabricant18739646
Nom chimique ou matériau(R)-1-((3 S,6 S,9 S,12 S,18 R,21 S,22 R)-21-acetamido-18-benzyl-3-((R)-1-methoxyethyl)-4,9,10,12,16,22-hexamethyl-15-methylene-2,5,8,11,14,17,20-heptaoxo-1,19-dioxa-4,7,10,13,16-pentaazacyclodocosan-6-yl)-2-methylpropyl (2 S,3 R)-2-acetamido-3-hydroxy-4-methylpent
CAS568580-02-9
Quantité1 mg
CibleGTPase Inhibitors
Formule moléculaireC<sub>46</sub>H<sub>69</sub>N<sub>7</sub>O<sub>15</sub>
Pureté0.95
Une question, une configuration particulière ?
Contactez-nous pour un devis.
Demander un devis 03 65 67 15 79

Produits similaires

Tocris&trade;&nbsp;VU 0134992

Tocris™ VU 0134992

951,38 € HT
Tocris&trade;&nbsp;VU 0134992

Tocris™ VU 0134992

245,13 € HT
Tocris&trade;&nbsp;GSK 1016790A

Tocris™ GSK 1016790A

1 095,00 € HT
Tocris&trade;&nbsp;GSK 1016790A

Tocris™ GSK 1016790A

276,45 € HT